Interaction of amyloid beta-protein with anionic phospholipids:: Possible involvement of Lys28 and C-terminus aliphatic amino acids

被引:103
作者
Chauhan, A [1 ]
Ray, I [1 ]
Chauhan, VPS [1 ]
机构
[1] New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA
关键词
amyloid beta-protein; Alzheimer's disease; lipids; phospholipids; fibrillization;
D O I
10.1023/A:1007509608440
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fibrillar amyloid beta-protein (A beta) is the major protein of amyloid plaques in the brains of patients with Alzheimer's disease (AD). The mechanism by which normally produced soluble A beta gets fibrillized in AD is not clear. We studied the effect of neutral, zwitterionic, and anionic lipids on the fibrillization of A beta 1-40. We report here that acidic phospholipids such as phosphatidic acid, phosphatidylserine, phosphatidylinositol (PI), PI 4-phosphate, PI 4.5-P-2 and cardiolipin can increase the fibrillization of A beta, while the neutral lipids (diacylglycerol, cholesterol, cerebrosides), zwitterionic lipids (phosphatidylcholine, phosphatidylethanolamine, sphingomyelin) and anionic lipids lacking phosphate groups (sulfatides, gangliosides) do not affect A beta fibrillization. A beta was found to increase the fluorescence of 1-acyl-2-[12-[(7-nitro-2-1, 3-benzoxadiazol-4-yl) amino] dodecanoyl]-sn-glycero-3-phosphate (NBD-PA) in a concentration-dependent manner, while no change was observed with 1-acyl-2- [12-[(7-nitro-2-1, 3-benzoxadiazol-4-yl) amino] dodecanoyl]-sn-glycero-3-phosphoethanolamine (NBD-PE). Under similar conditions, other proteins such as apolipoprotein E, gelsolin and polyglutamic acid did not interact with NBD-PA. The order of interaction of amyloid beta-peptides with NBD-PA was A beta 1-43 = A beta 1-42 = A beta 17-42 > A beta 1-40 = A beta 17-40. Other A beta peptides such as A beta 1-11, A beta 1-16, A beta 1-28, A beta 1-38, A beta 12-28, A beta 22-35, A beta 25-35, and A beta 31-35 did not increase the NBD-PA fluorescence. These results suggest that phosphate groups, fatty acids, and aliphatic amino acids at the C-terminus end of A beta 1-40/A beta 1-42 are essential for the interaction of A beta with anionic phospholipids, while hydrophilic A beta segment from 1-16 amino acids does not participate in this interaction. Since positively charged amino acids in A beta are necessary for the interaction with negatively charged phosphate groups of phospholipids, it is suggested that Lys(28) Of A beta may provide anchor for the phosphate groups of lipids, while aliphatic amino acids (Val-Val-Ile-Ala) at the C-terminus of A beta interact with fatty acids of phospholipids.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 42 条
  • [1] HYDROGEN-PEROXIDE MEDIATES AMYLOID-BETA PROTEIN TOXICITY
    BEHL, C
    DAVIS, JB
    LESLEY, R
    SCHUBERT, D
    [J]. CELL, 1994, 77 (06) : 817 - 827
  • [2] RAPID INDUCTION OF ALZHEIMER A-BETA AMYLOID FORMATION BY ZINC
    BUSH, AI
    PETTINGELL, WH
    MULTHAUP, G
    PARADIS, MD
    VONSATTEL, JP
    GUSELLA, JF
    BEYREUTHER, K
    MASTERS, CL
    TANZI, RE
    [J]. SCIENCE, 1994, 265 (5177) : 1464 - 1467
  • [3] CHAUHAN A, 1994, NEUROBIOL AGING, V15, P555
  • [4] CHAUHAN A, 1996, ALZHEIMERS RES, V2, P243
  • [5] CHAUHAN A, ALZHEIMERS DIS ADV C, P431
  • [6] CA(PHOSPHATIDATE)2 CAN TRAVERSE LIPOSOMAL BILAYERS
    CHAUHAN, VPS
    BROCKERHOFF, H
    [J]. LIFE SCIENCES, 1984, 35 (13) : 1395 - 1399
  • [7] X-RAY-DIFFRACTION EVIDENCE FOR MYELIN DISORDER IN BRAIN FROM HUMANS WITH ALZHEIMERS-DISEASE
    CHIA, LS
    THOMPSON, JE
    MOSCARELLO, MA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 775 (03) : 308 - 312
  • [8] A POTENTIAL ROLE FOR APOPTOSIS IN NEURODEGENERATION AND ALZHEIMERS-DISEASE
    COTMAN, CW
    ANDERSON, AJ
    [J]. MOLECULAR NEUROBIOLOGY, 1995, 10 (01) : 19 - 45
  • [9] DIPHOSPHOINOSITIDE AND TRIPHOSPHOINOSITIDE IN ANIMAL TISSUES
    DAWSON, RMC
    EICHBERG, J
    [J]. BIOCHEMICAL JOURNAL, 1965, 96 (03) : 634 - &
  • [10] Membrane phospholipid alterations in Alzheimer's disease: Deficiency of ethanolamine plasmalogens
    Farooqui, AA
    Rapoport, SI
    Horrocks, LA
    [J]. NEUROCHEMICAL RESEARCH, 1997, 22 (04) : 523 - 527